R. Douglas Norby, Director at Krystal Biotech, Inc. (KRYS), bought 9,000 shares at $10.42 ($94K) on 2018-05-09, disclosed to the SEC on 2018-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2012-12-12 | $2.0M | — | Filing → |
| ALXN | SELL | 2012-03-12 | $2.6M | — | Filing → |
| ALXN | SELL | 2011-10-31 | $3.1M | — | Filing → |